Market volatility creates opportunity

Fears around artificial intelligence and higher oil prices are weighing on global markets, but some stocks offer solid growth prospects even in choppy times.

UnitedHealth beats and raises

Health insurer UnitedHealth delivered better-than-expected third quarter results for twenty twenty-six and raised its full-year earnings outlook, reflecting progress on its turnaround plan.

Morgan Stanley upgrades UnitedHealth

Morgan Stanley analyst Erin Wright reiterated a buy rating on UNH stock with a price target of five hundred twenty nine dollars.

“UNH's beat & raise reinforces turnaround momentum, with improving MA/Optum Health supporting a higher '26 EPS baseline & upside to '27 consensus.”

Meta's AI agent gains traction

Meta Platforms launched its Muse AI agent, which is seeing solid traction. Muse reached one point three million daily active users in five weeks versus three hundred thousand in the first week.

Guggenheim raises Meta price target

Guggenheim analyst Michael Morris maintained a buy rating on Meta stock and increased his price target to eight hundred fifty dollars from seven hundred, reflecting higher estimates for twenty twenty-seven.

“Over time, we believe Muse monetizes primarily through businesses paying to reach consumers through their agents, consistent with the economics of Meta's core advertising business.”

Marvell raises AI-driven targets

Semiconductor company Marvell Technology raised its total addressable market estimate to four hundred billion dollars by twenty thirty, reflecting solid AI-led demand tailwinds at its Investor Day.

Stifel backs Marvell expansion

Stifel analyst Tore Svanberg reiterated a buy rating on Marvell with a price target of three hundred seventy dollars.

Marvell secures supply chain support

Management said it met with suppliers ahead of Investor Day to share its five-year goals and received commitments to support these targets. Svanberg believes these supply chain commitments give Marvell a competitive edge.